CASE STUDY

When Pediatric Access Risked Delays, We Prepared the Market Ahead of Launch.

CASE STUDY   |   PAYER COMMUNICATIONS

When Pediatric Access Risked Delays, We Prepared the Market Ahead of Launch.

THE CHALLENGE

Expanding Access to a New Pediatric Population Without Delaying Launch

A biopharmaceutical company launched a treatment for adults with narcolepsy, achieving strong coverage and pull-through with sleep specialists.

Ahead of a pediatric indication, the company needed to avoid unnecessary denials or access delays at launch. Payers would need to evaluate prior authorization requirements for a new pediatric population, while many prescribers were less familiar with treatment and approval pathways.

THE BREAKTHROUGH

Shifting Access Preparation Upstream to Remove Friction at Launch

Using our Breakthrough Process, powered by 3D Science, BGBx Market Access identified that access risk was driven not by policy alone, but by a lack of early alignment across payers and prescribers.

The strategy shifted access preparation upstream, ensuring prior authorization expectations, prescribing workflows, and access pathways were clearly defined before launch to reduce friction at the point of prescribing.

The Solution

  • Pre-Approval Information Exchange enabled payers to anticipate pediatric PA requests
  • HCP communications clarified prior authorization requirements and approval pathways
  • Field reimbursement and hub support provided targeted guidance to support PA approval
Perspective
“Shifting access preparation upstream allowed us to align key stakeholders early, streamline prior authorization, and support uptake at launch.”
— BGBx Market Access Lead

THE RESULTS

Successful Pediatric Launch with Improved PA Execution

Pre-approval and launch investments supported a successful pediatric launch and pull-through. Pediatric PA requests reflected established best practices, submissions were successfully implemented and approved, and PA processes were streamlined at launch.

PIE
Pre-Approval Exchange

Payers aligned before launch

PA
Streamlined Process

Improved execution at launch

HCP
Provider Education

Clearer access pathways

Let’s Build Your Next Market Access Breakthrough

At BGBx, we design access and communication strategies that prepare stakeholders ahead of launch, helping reduce friction and support uptake when it matters most. Let’s build your next breakthrough together.

2026 Oncology Market Access TrendsBLOG

2026 Oncology Market Access Trends

1 min
Implications of the IRA’s Maximum Fair Price (MFP) NegotiationsBLOG

Implications of the IRA’s Maximum Fair Price (MFP) Negotiations

1 min
340B Drug Discount ProgramBLOG

340B Drug Discount Program

1 min